Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis
<h3>Background</h3><p dir="ltr"><u>Chronic obstructive pulmonary disease </u>(COPD) significantly impacts global health due to persistent airflow limitation and inflammation. Despite standard therapies, symptoms persist. Ensifentrine, targeting both <u>b...
محفوظ في:
| المؤلف الرئيسي: | Ambanna Yappalparvi (21260018) (author) |
|---|---|
| مؤلفون آخرون: | Ashok Kumar Balaraman (22282333) (author), G. Padmapriya (22282336) (author), Shilpa Gaidhane (745829) (author), Irwanjot Kaur (20767955) (author), Madan Lal (773504) (author), Suhaib Iqbal (20767958) (author), G.V. Siva Prasad (22282339) (author), Atreyi Pramanik (8334333) (author), Teena Vishwakarma (20767964) (author), Praveen Malik (6560504) (author), Promila Sharma (14322356) (author), Ankit Punia (20767967) (author), Megha Jagga (20767970) (author), Doddolla Lingamaiah (22282342) (author), Rachana Mehta (12059853) (author), Sanjit Sah (19709571) (author), Quazi Syed Zahiruddin (13231791) (author), Hashem Abu Serhan (16003271) (author), Muhammed Shabil (16677981) (author), Ganesh Bushi (19709574) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Efficacy and safety of ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor, in chronic obstructive pulmonary disease: A systematic review and meta-analysis
حسب: Eeshal Fatima (18255772)
منشور في: (2024) -
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
حسب: Derek K., Chu
منشور في: (2023) -
Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors
حسب: Wesam S. Ahmed (10170053)
منشور في: (2021) -
Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials
حسب: Ibrahim Elmakaty (14614270)
منشور في: (2023) -
Safety and efficacy of a ten day helicobacter pylori eradication regimen with rabeprazole, amoxicillin and clarithromycin. (c2003)
حسب: Farchoukh, Lina
منشور في: (2003)